Keiichi Fukuda, CEO at Heartseed Inc. is speaking at this year's Cell & Gene Therapy World Asia Summit in September 15-16, presenting "Treatment of severe congestive heart failure by transplanting human iPS cell-derived purified ventricular cardiomyocytes".

Join us in Singapore to learn more about the fast advancement in new therapies, R&D and biomanufacturing.

https://imapac.com/cell-and-gene-therapy-asia/